Viemed Healthcare (VMD) COO logs RSU vesting and tax share sales

Rhea-AI Filing Summary

Viemed Healthcare, Inc. Chief Operating Officer and director William Todd Zehnder reported equity compensation vesting and related tax share dispositions. On January 29, 2026, 26,842 restricted stock units converted into an equal number of common shares, and 8,948 cash-settled phantom share units vested, each economically equivalent to one common share.

The company withheld 11,368 common shares at $7.48 per share and a further 8,948 common shares at the same price to cover tax obligations tied to these awards. After these transactions, Zehnder directly owned 390,309 common shares of Viemed Healthcare.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZEHNDER WILLIAM TODD

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE LA 70508

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/29/2026		M		26,842	A	(1)	401,677	D
Common Shares	01/29/2026		F		11,368(2)	D	$7.48(3)	390,309	D
Common Shares	01/29/2026		M		8,948	A	(4)	399,257	D
Common Shares	01/29/2026		D		8,948	D	$7.48(3)	390,309	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	01/29/2026		M			26,842	(5)	01/29/2027	Common Shares	26,842	$0	26,842	D
Phantom Share Units	(4)	01/29/2026		M			8,948	(6)	01/29/2027	Common Shares	8,948	$0	8,946	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

2. Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.

3. Per share value is based on the market closing price of the common shares for January 29, 2026.

4. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.

5. Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date.

6. Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Viemed Healthcare (VMD) COO report in this Form 4 filing?

Viemed Healthcare’s COO William Todd Zehnder reported vesting of restricted stock units and phantom share units, plus related tax share dispositions. The transactions on January 29, 2026 resulted in equity awards converting into common shares and shares withheld to satisfy associated tax obligations.

How many Viemed Healthcare RSUs vested for the COO on January 29, 2026?

26,842 restricted stock units vested for COO William Todd Zehnder, each converting into one Viemed Healthcare common share. These RSUs were part of a grant dated January 29, 2024 that vests in three equal annual installments beginning on the first anniversary of the grant date.

What are the phantom share units reported by Viemed Healthcare’s COO?

The phantom share units are cash-settled awards under Viemed’s Phantom Share Unit Plan, each economically equivalent to one common share. On January 29, 2026, 8,948 phantom units vested, with settlement reported as acquisition and simultaneous disposition of the underlying common shares for cash.

At what price were Viemed Healthcare shares used to cover the COO’s taxes?

Common shares withheld to satisfy William Todd Zehnder’s tax obligations were valued at $7.48 per share. This per-share value was based on the market closing price of Viemed Healthcare common shares on January 29, 2026, the date the equity awards vested and settled.

How many Viemed Healthcare common shares does the COO own after these transactions?

Following the January 29, 2026 transactions, COO William Todd Zehnder directly owned 390,309 Viemed Healthcare common shares. This figure reflects RSU and phantom unit vesting, along with shares withheld or disposed of to cover tax liabilities arising from those equity awards.

When were the Viemed RSUs and phantom share units originally granted to the COO?

The restricted stock units and phantom share units were granted on January 29, 2024. Both awards vest in three equal annual installments beginning on the first anniversary of the grant date, creating scheduled vesting events such as the one reported on January 29, 2026.